UPDATE 1-CTI BioPharma blood cancer drug meets main goal in trial
March 09, 2015 at 07:51 AM EDT
March 9 (Reuters) - CTI BioPharma Corp said its experimental blood cancer treatment achieved the main goal of a late-stage study, sending its shares up 24 percent in premarket trading.